AMDL Announces Launch Of Antibiotic Levofloxacin In China
Sat, 18 Nov 2006 08:00 AM EST
... AMDL (Amex: ADL) announced today that its China subsidiary, Jade Pharmaceutical Inc., has received approval from the China State Food and Drug Administration (SFDA) for the antibiotic levofloxacin. Levofloxacin is used to treat infections including pneumonia, urinary tract, kidney and skin infection. It is in a class of antibiotics called fluoroquinolones. [click link for full article] ...
Related Topics
- Antibiotics
- Antibiotic Resistance
- Hydrocortisone, Neomycin, and Polymyxin Otic
- Levofloxacin Oral
- China
- Levofloxacin ophthalmic
- Avian Influenza
- Levofloxacin Injection
- Adoption
- Insulin glargine
- Antibiotic-associated diarrhea
- Polymyxin B, Bacitracin, and Neomycin
- Cefuroxime
- Cephalexin
- Viral Infections
- Travel
- Culture
- Plum blossom
- CCP
- Sulfamethoxazole and Trimethoprim

Not Signed In -


